Search research articles
Contact Us
Filters
Showing results (81-90 of 673) with videos related to
Page
of 68
Sort By:
Molecular Immunology
|
January 1, 2013
BST-2/tetherin: structural biology, viral antagonism, and immunobiology of a potent host antiviral factor
Melissa Swiecki, Natalie S Omattage, Tom J Brett
BMJ Open
|
October 9, 2020
Patient or family perceived deterioration in functional status and outcome after intensive care admission: a retrospective cohort analysis of routinely collected data
Jamie L Gross, Jacek Borkowski, Stephen J Brett
British Journal of Anaesthesia
|
December 9, 2016
Association between day and time of admission to critical care and acute hospital outcome for unplanned admissions to adult general critical care units: cohort study exploring the 'weekend effect'
N Arulkumaran, D A Harrison, S J Brett
Infection and Immunity
|
May 29, 2014
Proteomic analysis of the Burkholderia pseudomallei type II secretome reveals hydrolytic enzymes, novel proteins, and the deubiquitinase TssM
Mary N Burtnick, Paul J Brett, David DeShazer
Drugs
|
February 12, 2017
New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development?
Michael Berry, Brijesh V Patel, Stephen J Brett
Clinical and Experimental Immunology
|
August 1, 1985
Adoptive cell transfer of resistance to Mycobacterium leprae infections in mice
C Lowe, S J Brett, R J Rees
Ergonomics
|
March 17, 2017
Impossible decision? An investigation of risk trade-offs in the intensive care unit
Tom W Reader, Geetha Reddy, Stephen J Brett
International Journal of Systematic Bacteriology
|
May 2, 1998
Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species
P J Brett, D DeShazer, D E Woods
Annual Review of Microbiology
|
June 10, 2010
Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis
Edouard E Galyov, Paul J Brett, David DeShazer
Molecular Microbiology
|
February 13, 1999
The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence
D DeShazer, P J Brett, D E Woods
Page
of 68
Search research articles
Search
Showing results (81-90 of 673) with videos related to
Sort By:
Page
of 68
Molecular Immunology
|
January 1, 2013
BST-2/tetherin: structural biology, viral antagonism, and immunobiology of a potent host antiviral factor
Melissa Swiecki, Natalie S Omattage, Tom J Brett
BMJ Open
|
October 9, 2020
Patient or family perceived deterioration in functional status and outcome after intensive care admission: a retrospective cohort analysis of routinely collected data
Jamie L Gross, Jacek Borkowski, Stephen J Brett
British Journal of Anaesthesia
|
December 9, 2016
Association between day and time of admission to critical care and acute hospital outcome for unplanned admissions to adult general critical care units: cohort study exploring the 'weekend effect'
N Arulkumaran, D A Harrison, S J Brett
Infection and Immunity
|
May 29, 2014
Proteomic analysis of the Burkholderia pseudomallei type II secretome reveals hydrolytic enzymes, novel proteins, and the deubiquitinase TssM
Mary N Burtnick, Paul J Brett, David DeShazer
Drugs
|
February 12, 2017
New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development?
Michael Berry, Brijesh V Patel, Stephen J Brett
Clinical and Experimental Immunology
|
August 1, 1985
Adoptive cell transfer of resistance to Mycobacterium leprae infections in mice
C Lowe, S J Brett, R J Rees
Ergonomics
|
March 17, 2017
Impossible decision? An investigation of risk trade-offs in the intensive care unit
Tom W Reader, Geetha Reddy, Stephen J Brett
International Journal of Systematic Bacteriology
|
May 2, 1998
Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species
P J Brett, D DeShazer, D E Woods
Annual Review of Microbiology
|
June 10, 2010
Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis
Edouard E Galyov, Paul J Brett, David DeShazer
Molecular Microbiology
|
February 13, 1999
The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence
D DeShazer, P J Brett, D E Woods
Page
of 68